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ABSTRACT 
Introduction: 
Many people living with advanced dementia live and die in nursing care homes. The quality of life, 
care and dying experienced by these people is variable. Namaste Care is a multi-sensory programme 
of care developed for people with advanced dementia. Whilst there is emerging evidence that 
Namaste Care may be beneficial for people with dementia, there is a need to conduct a feasibility 
study to establish the optimum way of delivering this complex intervention and whether benefits can 
be demonstrated in end of life care, for individuals and service delivery. The aim of the study is to 
ascertain the feasibility of conducting a full trial of the Namaste Care intervention. 
 
Methods and analysis: 
A feasibility study, comprising a parallel, two-arm, multi-centre cluster controlled randomised trial 
with embedded process and economic evaluation.  Nursing care homes (total of 8) who deliver care 
to those with advanced dementia will be randomly allocated to intervention (delivered at nursing care 
home level) or control. Three participant groups will be recruited: residents with advanced dementia; 
informal carers of a participating resident and nursing care home staff.  Data will be collected for 6 
months. Feasibility objectives concern the recruitment and sampling of nursing homes, residents, 
informal carers and staff; the selection and timing of primary (quality of dying and quality of life) and 
secondary clinical outcome measures (person centeredness, symptom presence, agitation, quality of 
life, resource use and costs and residents’ activity monitored using actigraphy). Acceptability, fidelity 
and sustainability of the intervention will be assessed using semi-structured interviews with staff and 
informal carers 
Ethics and dissemination:  This protocol has been approved by NHS Wales Research Ethics Committee 
5 (Ref: 17/WA0378). Dissemination plans include working with a public involvement panel, through a 
website (wwww.namastetrial.org.uk), social media, academic and practice conferences and via peer 
reviewed publications.  
 
Registration: ISRCTN14948133  
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Strengths and Limitations of this study 
 Intervention trialled is based on a theoretical model of how the intervention works, drawn 
from current evidence base, and consultation with care home staff, family and experts  
 PPI will greatly inform the ongoing development of the research design and delivery and assist 
in recruitment, analysis and dissemination 
 Both proxy and objective measures will be measured with this hard to research population 
 Blinding is not possible, due to the nature of the intervention 
 The study will not provide data on the effectiveness of the intervention, but will indicate if a 
further trial to establish effectiveness is feasible  
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INTRODUCTION 
Background  
Dementia is a life limiting condition, with a median survival, decreasing with age, of 6.7 to 1.9 years.1 
In advanced dementia, an individual requires full assistance with care, is chair or bedbound, doubly 
incontinent and no longer able to communicate verbally (FAST scale 6-7).2 People with dementia often 
experience a poor quality of death, preceded by a period of poor quality of life, with over and under 
treatment occurring.3-5 There is an increasing urgency for appropriate care that will ensure a good 
quality of life and dying are achieved.5, 6  
Evidence for therapeutic healthcare interventions for people with advanced dementia is limited. 
Reviews of therapies such as music therapy indicate mixed outcomes for people with dementia, with 
a Cochrane review identifying equivocal evidence.7 More recent reviews of therapeutic interventions 
have identified large positive effects on behavioural, cognitive and physiological outcomes,8 to 
moderate effects on anxiety with small effects on behavioural symptoms and evidence for short term 
improvement in mood and reduction in behavioural disturbance.9, 10 In a Cochrane review of touch 
therapies, some evidence of an effect was identified, but not specifically for people with advanced 
dementia.11 A recent review indicated that massage reduced levels of agitation.12 Interventions 
supporting person-centred care have been shown to reduce agitation and behavioural disturbance. 
There is some evidence for individualised interventions, within a bio-psychosocial framework, 
improving behavioural symptoms.13-15 
Interventions with a single focus on reducing pain, physical symptoms or specific behavioural 
disturbances have been found to be effective.3 It is recognised that for people with advanced 
dementia there is a need for interventions that complement and enhance pharmacological 
interventions. This study addresses the lack of evidence available through completed research, to 
consider the stage specific efficacy of non-pharmacological interventions.16 There is also a need for 
practical interventions that staff can learn to deliver which allow them to provide person-centred care. 
Palliative and end of life care interventions for people with dementia that emphasise a person-centred 
philosophy, and use co-design approaches, are being developed and tested.17 Namaste Care is one 
such intervention. Non-randomised research studies have identified that Namaste Care at the end of 
life reduces the severity of behavioural and physical symptoms and occupational disruptiveness and 
may have an impact on social interaction, delirium and agitation.18-22 The potential for cost savings 
with respect to reduced psychotropic medication use has also been indicated.19, 23 Qualitative 
evidence suggests greater family and staff satisfaction with care.18 However, none of these studies 
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have compared this intervention with other approaches to palliative and end of life care for this 
population. We do not yet know the optimum way of delivering this complex intervention and which 
benefits (including cost-effectiveness) can be demonstrated in end of life care, for individuals and 
service delivery. 
In Phase 1 of this study, a realist review of 85 papers that considered Namaste Care and sensory 
interventions (such as music therapy or massage) for people with advanced dementia identified three 
context-mechanism-outcome configurations. This indicated what needs to be in place for Namaste 
Care to work for this population. The overarching theme was the importance of providing activities 
that enabled the development of moments of connection for people with advanced dementia. This 
can occur when the following three elements are in place: provision of structured access to stimulation 
(social and physical), equipping care home staff to be able to cope with complex variable behaviours, 
and providing a framework for person-centred care.   
 
Intervention Development 
The Namaste Care intervention is already promoted using existing resources. 24, 25 In this study, a four-
stage approach to the development and refinement of the intervention resources was used. This 
entailed: 1. Collating the existing intervention materials and the findings of the realist review to draft 
an intervention description; 2. Exploring the readability, comprehensibility and utility of the materials 
with staff unfamiliar with Namaste Care; 3. Using a modified nominal group techniques with people 
with Namaste Care experience to refine and prioritise the intervention implementation materials; and 
4. Final refinement with the study’s patient and public involvement panel.  This led to production of a 
16 page A4 booklet. The booklet included the use of flow charts, graphics and colour coded 
information supported by infographics, and a training package.  
Therefore, we propose undertaking a feasibility cluster controlled randomized trial in a nursing care 
home context between 01 Jan 2018 to 31 March 2019.  
 
Aims and Objectives 
The primary objective of this feasibility study is to ascertain the feasibility of conducting a full trial of 
the Namaste Care intervention.  
The feasibility issues associated with the research design and data collection processes to enable the 
design of a full trial to determine the efficacy of Namaste Care are: 
a) To understand how best to sample and recruit nursing homes into a cluster randomised  
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controlled trial of Namaste Care; 
b) To determine the most appropriate selection, timing and administration of primary and 
secondary outcome measures for a full cluster randomised controlled trial of Namaste Care 
against criteria of bias minimization, burden, and acceptability;  
c) To establish recruitment, retention and attrition rates at the level of the nursing home and 
individual resident, informal carer and nursing home staff;  
d) To establish the willingness of a large number of nursing homes representing the range of 
nursing homes, with respect to provider type, size, resident care needs, to participate in a full 
trial; 
e) To assess the acceptability, fidelity and sustainability of the Namaste Care intervention.  
 
Secondary objectives include resident levels of sleep/activity, neuropsychiatric symptoms and pain, 
informal carer satisfaction with care at the end of life staff care giving experiences and satisfaction 
with care in end of life care. Health economic and healthcare resource use will also be assessed. 
 
METHODS AND ANALYSIS 
Trial Design 
A feasibility study consisting of a parallel, two-arm, multi-centre cluster controlled randomised trial 
design with an embedded process evaluation is to be conducted. The clustering will take place at the 
nursing care home level. The Namaste Care programme in the intervention arm will be compared with 
the standard programme of care used in the control homes. 
 
Study Population 
Nursing Care Homes 
Eight nursing care homes based in the North West of England already using a recognised palliative 
care programme (for example, Gold Standards Framework for Care Homes, Six Steps to Success or 
equivalent) will be recruited into the study. Two nursing care homes will be allocated to the control 
arm whilst six nursing care homes will be allocated to the intervention arm. To meet the eligibility 
criteria, the nursing care home needs to have:   
1. at least 30 beds 
2. 6 residents who meet the resident eligibility criteria 
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3. the space to run the Namaste Care programme 
4. a manager or a nominated person to act as the Principal Investigator. 
 
A nursing care home will not be eligible to join the study if they: 
1. are rated as Needs Improvement or Inadequate in the latest CQC inspection 
2. are subject to CQC enforcement notices 
3. have already introduced Namaste Care in their nursing care home 
4. are currently involved in another research study that conflicts with this study. 
 
Individual Participants 
Residents – To meet the resident eligibility criteria, a resident has to:  
1. be a permanent resident living in the participating nursing care home 
2. lack mental capacity 
3. have a formal assessment of advanced dementia based on the Functional Assessment 
of Staging of Alzheimer’s Disease (FAST) score of 6-7 made by the nursing care home 
manager or another experienced member of staff  
4. have a key worker member of staff willing to complete outcome tools. 
 
A resident will be ineligible to participate in the study if the resident:  
1. is permanently bedbound  
2. is currently or has recently been involved in another research study that conflicts with 
Namaste Care or with data collection during the course of the Namaste Care study. 
 
Informal carer – To meet the informal carer eligibility criteria, a person who: 
1. is 18 years and over 
2. can communicate in English   
3. self-defines as a relative or a friend and acts a carer for a resident enrolled to take 
part in the study.  
 
A person will not be eligible to participate in the study if:  
1. their relative or friend is a resident and has not been enrolled in to the study. 
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Nursing care home staff – To meet the nursing care home eligibility criteria, a person has to be  
1. a member of health and social care staff paid to provide care to residents with 
advanced dementia within participating nursing care homes. 
 
Nursing care home staff will not be eligible to participate in the study if 
1. they are in the intervention arm and they have delivered the Namaste Care 
programme or cared for residents receiving Namaste Care in a nursing care home not 
involved in this study.  
 
Sample Size and Selection 
As the aim of this study is to establish feasibility of a full trial, a formal sample size calculation was not 
carried out. A sample size of 8 nursing homes (6 intervention and 2 controls) has been selected as it 
offers a reasonable test of the intervention to assess the feasibility objectives. There have been a 
range in the sample sizes used in feasibility studies in nursing homes ranging from 2,26 6 to 14.27  
Eligible nursing care homes will be identified through online resources such as the ENRICH database. 
Following the initial identification, contact will be made with managers of the nursing care home to 
discuss the study and confirm the eligibility of the nursing care home. Consent for the homes will be 
assumed when the manager of the facility signs a contract drawn up by the Sponsor, Lancaster 
University.   
 
Randomisation 
The randomisation of participating nursing care homes to either the intervention arm or the control 
arm will be undertaken by statisticians from the Clinical Trials Research Centre (CTRC) at the University 
of Liverpool randomisation team who will not be involved in the study. Due to the clustered 
randomisation approach of this study, all study participants will be assigned to the same study arm as 
the nursing care home they are associated with.  The nature of the intervention and its delivery means 
that it will not be possible to blind nursing homes or staff to the allocation status. If possible, to 
minimise potential for bias, staff involved in the delivery of the Namaste Care intervention will not be 
involved in the completion of outcome measures. It will not be possible to blind researchers to the 
allocation of nursing homes, as the intervention requires changes to the nursing home environment 
which may be visible to any researcher visiting the facility.   
The study flow chart of activities (Figure 1) shows the recruitment process to be followed.  
9 
 
 
Consent Procedures 
Individual Participants  
Residents – Potentially eligible residents will be screened by the Principal Investigator and the senior 
care team at each nursing care home. Consent for the eligible residents will be sought from a personal 
consultee of the resident in the first instance. If a person consultee does not reply within month of 
been given the invitation pack then assent will be taken from either a nominated consultee or the 
process used by the nursing care home in question. Once permission is granted by the personal 
consultee, members of the research team will discuss the study with the personal consultee and gain 
assent for residents to take part in the study.  Process consent will also be considered for the resident 
participant group.28 Therefore, if a resident shows signs of not wanting to take part in the Namaste 
Care session they will be allowed to miss the Namaste Care session and still continue in the trial.  
Informal carer – The informal carers of residents enrolled to the study will be identified by the Principal 
Investigator and the senior care team at each nursing care home and invited to consent to complete 
questionnaires and participate in a qualitative interview.  
Nursing care home staff – Nursing care home staff interested in taking part in the Namaste Care study 
will be identified by the nursing care home manager. Upon identification, researchers will discuss the 
study with the identified staff members and obtain written consent from each staff member. 
A research lead will be appointed in each nursing care home. The research lead will be tasked with 
ensuring the paperwork associated with clinical research and the Investigator Site File is maintained. 
The research lead, and the Principal Investigator from the intervention sites and the control sites will 
be invited to a training day for guidance on selection of participants and completion of data collection 
forms and maintaining the Investigator Site File.  
Participants will be followed for six months after the commencement of the Namaste Care 
intervention in each nursing care home in the intervention arm or after the recruitment of the first 
four residents in the nursing care home for sites in the control arm.  
 
Intervention 
The intervention is a programme of care (Namaste Care), delivered in the intervention care homes by 
care staff working in the facility.  The following description uses the TIDieR guidelines for intervention 
description (items 1-9).29   
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Namaste Care seeks to give comfort and pleasure to people with advanced dementia through 
engagement, meaningful and creative activities as well as sensory stimulation to reflect the resident’s 
‘life story’24. Supporting resource materials have been developed which provide the following 
guidance regarding the implementation of Namaste Care programme.  
 The Namaste Care sessions should be undertaken within a designated space in the nursing 
home. This space could be within another room, or a room which is used for other purposes  
 The environment of the designated space must be made ‘special’ and should enable a feeling 
of calm i.e. welcoming and homely, with natural or slightly dimmed lighting, perhaps attractive 
scents, such as lavender from an aromatherapy diffuser, and with soft music playing 
 The Namaste Care sessions should be undertaken in a group setting 
 Food and drink should be offered to the residents 
 A minimum of two nursing home staff members or volunteers should be present to run the 
Namaste Care sessions 
 The duration and frequency of Namaste Care delivery as proposed by its originator (two hours 
a day, twice a day, seven days a week) will be promoted.24 
 
Namaste Care champions will be appointed in each nursing care home in the intervention arm.  At 
least two care staff (registered nurses, care assistants or activity coordinators) will attend a one day 
workshop about Namaste Care, led by an experienced external facilitator. A follow up training session 
will be held at each nursing care home to train more staff and provide advice on preparing the 
Namaste space.  
Prior to the commencement of enrolment, Namaste Care champions (Eligible nursing care homes will 
be identified in the intervention arm) will be appointed in each nursing care home. The Namaste Care 
champion will be invited to a training day for guidance on Namaste Care intervention, held at a site 
away from nursing care homes and undertaken by members of the research team and an external 
trainer. A follow up training session will be held at each nursing care home.   
 
Control Arm  
The care home manager of nursing care homes allocated to the control arm will be asked to continue 
delivering the usual care programme used in their facility. 
Training on the Namaste Care programme will be available to the nursing care homes in the control 
arm after the study has been completed. 
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Outcome and Study Measures  
We consider two contender primary outcomes for a full trial: (1) quality of dying (dementia) (CAD-
EOLD) and (2) quality of life (QUALID) (Table 1 -4). 30, 31 
The secondary outcome measures in this trial (Table 1) will measure: measure person-centeredness, 
symptom presence, agitation, quality of life, resource use and costs; and sleep and activity using 
actigraphy.32-37 Semi-structured interviews with staff and informal carers will assess perceptions of 
Namaste Care or usual care, assessment of the fidelity, acceptability and appropriateness of Namaste 
Care or of usual care. 
The outcome measures to be used are listed in Tables 1 – 4 and presented based on respondent type 
i.e. measures for residents (Table 1), informal carers (Table 2), staff (Table 3) and at the level of the 
nursing care home (Table 4). At the start of the study, descriptive data will be collected for all 
participating nursing care homes such as ownership and funding model, size, staffing, case mix, staff 
turnover, staff sickness/absence and geographical location. An interview with the nursing care home 
manager will also be conducted to ascertain the organisation’s readiness for change. 
   
Data Collection 
In this study, the outcome measures and process evaluation data will be gathered via 5 different 
methods: 
1) Questionnaires – The nursing home staff participant group and the informal carer 
participant group will be asked to complete written questionnaires at timepoints outlined 
in Tables 1 – 3. The questionnaires for the resident participant group will be proxy 
completed by nursing care home staff who are key workers for the participating residents. 
Note, the timeframe for baseline varies depending on the participant group. Data on 
nursing home level data about engagement with health and social care services will be 
collected using standardised data collection forms (Table 4) 
2) Objective measures – The participating residents will be asked to wear an actigraph watch-
like device for 28 days from the baseline visit. This actigraph will be placed on the wrist or 
ankle of the resident and will be used to continuously measure sleep and activity 
3) Interviews - Semi-structured interviews will be undertaken at the baseline with the 
nursing home manager and at the end of the data collection period with family carers and 
care staff 
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4) Observations of the residents will be undertaken intermittently during the delivery of the 
care programme and during the delivery of usual care in the control sites 
5) Data logs will be completed in the intervention sites using a proforma to record 
intervention delivery.  
 
Feasibility Work for Economic Evaluation 
The use of a number of potential outcome measures will be explored in terms of feasibility and 
acceptability of proxy completion with the particular population, evaluated through the think aloud 
technique. The chosen measures are included in the NICE recommended measures for health and 
social care: EQ-5D-5L (5 items), the ICECAP-O (5 items) and the ICECAP-Supportive Care Measure 
(ICECAP-SCM) (7 items).38-40 A think aloud technique will also be used with the ICECAP-O, ICECAP-SCM 
and ICECAP-CPM tools for a proportion of participants at 2 weeks, 4 weeks and 24 weeks, to obtain 
20-30 think aloud interviews across a range of timepoints.41 This think aloud technique will be 
undertaken either via telephone or face to face. The feasibility of collecting resource use data through 
nursing home records will be assessed, and the cost of the interventions will be estimated, for use in 
a full evaluation. 
 
Process Evaluation  
The process evaluation elements of the study (Table 5) will address staff members’ perceptions of 
Namaste Care (intervention arm) or perceptions of the effectiveness of usual care (control arm) using 
interviews approximately 24 weeks after the first resident is recruited at the nursing home. Family 
carers’ perceptions of Namaste Care (intervention arm) or carers’ perceptions of the effectiveness of 
usual care (control arm) will be ascertained using interviews between 16-24 weeks after the first 
resident is recruited at the nursing home.   
To assess the fidelity, acceptability and appropriateness of Namaste Care (intervention arm) or assess 
effectiveness of usual care (Control arm) observation will be conducted at approximately 2 weeks, 4 
weeks and 24 weeks after the start of the intervention for nursing homes in the intervention arm and 
approximately 2 weeks and 4 weeks in the control arm.   
A data log will be completed by the staff delivering the Namaste Care session throughout the 
intervention delivery.  
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Data Management 
Data management is provided by the CTRC at the University of Liverpool.  Paper based case report 
forms will be written to record data in a consistent way and ensure, anonymization of the data. Data 
stored at the CTRC will be checked for missing or unusual values (range checks) and checked for 
consistency within participants over time. Any suspect data will be returned to the site in the form of 
data queries. Data query forms will be produced at the CTRC from the trial database and sent either 
electronically or through the post to a named individual (as listed on the site delegation log). Sites will 
respond to the queries providing an explanation/resolution to the discrepancies and return the data 
query forms to CTRC. The forms will then be filed along with the appropriate data collection forms and 
the appropriate corrections made on the database. The process of database lock, unlock and closure 
will be followed according to the CTRC policy.  
 
Data Analysis Plan 
Three types of data will be analysed: quantitative date from surveys and the actigraphs, qualitative 
data from interviews and economic data.  
 
Quantitative Analysis 
Outcomes at baseline and follow-up will be summarised using descriptive statistics and will be used 
to make a decision on undertaking a full trial. Analysis of the outcome data will focus on recruitment, 
response and completion rates, and missing data. Reasons for non-consent and missing outcome data 
will be reported. Estimates of standard deviation and proxy agreement will be determined, and 
construct validity estimated intracluster correlation coefficent will be made.  
The sleep/activity data from the actigraph will be analysed using summary statistics for the sleep 
analysis data (sleep/wake ratios, total sleep time, sleep efficiency, wake after sleep onset and total 
activity); participant’s rhythm fragmentation and synchronization will be estimated via Intradaily 
Variability (IV) and Interdaily Stability (IS).42, 43 The actigraph will be used to ascertain the feasibility of 
use this outcome measure to collect data in a full trial.  
 
Qualitative Analysis 
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Semi-structured interviews will be audio-recorded, transcribed and anonymised. Framework analysis 
will be used in the analysis of qualitative data, with data collection, management and analysis 
rigorously conducted to enable reporting against COREQ guidelines. Group/ individual interviews and 
observation sessions will be digitally audio-recorded and fully transcribed. NVivo™ will be used to 
facilitate data management and analysis as this supports framework analysis techniques. 
 
Analysis of Economic Data 
Economic assessments of relevant outcome measures will combine qualitative assessments of 
feasibility of use for the outcome measures gained through the think aloud techniques and more 
quantitative assessments of agreement between proxies, and assessments of construct validity for the 
measures.44 Response and completion rates will be assessed. Constant comparative analytical 
methods will be used to provide a more in-depth assessment of both the questionnaire completion 
and respondents’ perceptions of the measures in the think aloud interviews.  
Unit cost information will be generated using bottom-up costing for the Namaste intervention itself, 
ensuring that a cost for the intervention will be available in a full trial. Other sources of unit cost 
information will be identified and collated for use in a future full trial and will be applied to the 
collected resource use data to enable the preliminary assessment of costs and benefits, and the main 
cost drivers for a full evaluation. All data will be costed using unit cost data in pounds sterling, and 
from a single year, as close as possible to the end of the feasibility study. 
 
Public and Patient Involvement 
Two carer representatives from the Alzheimer’s Society Research Network UK were co-applicants as 
part of the core study/trial management group. They will be present at all project teleconferences and 
meetings. A Public Involvement Panel will be established in the north west of England. This will 
comprise of six to eight members, co-chaired by the PPI co-applicants. The members have personal 
experience of family members living with dementia in care homes. The panel members will work 
alongside the research team to assist in different areas of research including reviewing participant 
information sheets and other documentation, five face to face meetings are proposed during the 
study, and communication between meetings will be by regular updates. There will also be PPI 
representation on the research advisory group and Trial Steering Committee.  
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Monitoring and Trial Management  
For this research population there is a relatively high risk of death, hospitalisation or progression of 
disease for participants during the course of the study but which are not anticipated to be related to 
the receipt of the intervention. This level and type of risk will be treated as an acceptable risk for the 
purposes of the study and will not constitute adverse events (AE) or serious adverse events (SAE) 
unless concern is raised by anyone associated with the study that these events could be directly 
related to participation in this study. 
The Trial Management Group, is responsible for 1) protocol completion, 2) obtaining ethical approval 
for Phases 1 and 2, 3) obtaining ethical approval for Phase 3 plus nursing home approval process; 4) 
appointing and facilitating the Trial Steering Committee; 5) working with the dissemination partners. 
The group will meet for a ‘kick off’ meeting face to face at the start of the project. Thereafter there 
will be monthly teleconferences and twice yearly face to face meetings. The Trial Steering Committee 
(TSC), with an independent chair, will provide overall supervision of the trial including trial progress 
and participant safety. Membership will be drawn from experts in health services research, nursing 
home research, and PPI. They will meet prior to the start of the trial phase and then twice during the 
second year of the project. The TSC will have the role of a traditional Data Monitoring Committee as 
this a feasibility study with a low risk intervention. A TSC charter based on the guidelines published by 
the NIHR will be used to identify the remit of the TSC committee.  An International Advisory Group 
will also be established to provide external expert advice on the overall progress of the study.  There 
is a data management plan (held by the sponsor) which outlines data storage periods and future access 
to data.  
 
DISCUSSION 
This protocol describes the Namaste Care programme for residents with advanced dementia who are 
living in nursing care homes. The Namaste Care programme is a multi-sensory care programme 
conducted on a daily basis in a group setting. This study will provide information on implementation, 
cost and acceptability of a defined intervention. In addition, this study will provide information on 
usefulness, practicality and acceptability of the selected outcome measures and processes used in this 
study. In conclusion, the findings of this study will informal future research on the Namaste Care 
programme in nursing care homes.   
 
ETHICS AND DISSEMINATION 
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The study has been approved by the Wales Research Ethics Committee 5 (Ref: 17/WA/0378; Ver No 
04. Feb 09 2018). As resident’s eligible for the study will lack capacity to consent, consent for residents 
will be taken from either a personal consultee or a nominated consultee following the Mental Capacity 
Act (2005) guidance.28, 45  A procedure for reporting issues of concern in the care setting has been 
written.  
The following dissemination channels will be used: a project website (www.namastetrial.org.uk), a 
leaflet summarising the study, summaries of findings, publications/articles for general as well as 
scientific media and social media such as Twitter (@namasteresearch). All publications will follow the 
relevant reporting guidelines for reviews and trials.46 
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Table 1.  Summary of resident data collected by care home staff, outcome measures and time schedule  
Data collected and tool used 
P
re
- 
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M
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A
t 6
 m
o
n
th
s  
o
r d
eath
 
 
Socio-demographics Age, gender, ethnicity, existing medical conditions, Stage of dementia on FAST score  x x x  
Quality of dying Measure to assess quality of death using CAD-EOLD47, 48 x x x  
Quality of Life of the person with dementia EQ-5D-5L40 self-rated health index and visual analogue scale of current health state x x x  
Neuropsychiatric Inventory Measure to assess psychitriatic state of resident using NPI-Q38  x x x  
Pain Measure to assess level of pain using PAIN-AD35 x x x  
Quality of life  EQ-5D-5L x x x  
ICECAP Supportive Care Measure Health economic measure using ICEPCAP-SCM38 x x x  
ICECAP-O measure Health economic measure using ICEPCAP-O49 x x x - 
Cohen-Mansfield Agitation Inventory Measure to assess resident agitation36 x x x  
ICECAP Supportive Care Measure using Think Aloud Health economic measure using ICEPCAP-SCM using Think Aloud x x x  
ICECAP-O measure using Think Aloud Health economic measure using ICECAP-O using Think Aloud x x x  
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Table 2.  Summary of informal carer data collected, as assessed by informal carers, outcome measures and time schedule  
Data collected and tool used 
 B
ase
lin
e
 
A
t 1
 M
o
n
th
 
A
t 6
 m
o
n
th
s  
o
r d
eath
 
 
Socio-demographics Age, gender, ethnicity, existing medical conditions x - -  
Service use in the prior month Client Service Receipt Inventory (CSRI)50. Calculates service and total care costs x x x  
Quality of life of the carer EQ-5D-5L x x x  
Satisfaction with Care SWC-EOLD34 x x x  
Close person measure of health economic evaluation Health economic evaluation using ICECAP-CPM x x x  
Close person measure of health economic evaluation Health economic evaluation using ICEPCAP-CPM completing using Think Aloud x x x  
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Table 3.  Summary of staff data collected as assessed by care home staff: outcome measures and time schedule  
Data collected and tool used 
P
re
- 
in
te
rve
n
tio
n
 
M
o
n
th
ly 
A
t 6
 m
o
n
th
s 
o
n
ly 
P
o
st 
in
te
rve
n
tio
n
 
Staff socio-demographics Age, gender, ethnicity X - - - 
Staff work characteristics Highest qualification, role in care home, length of service X - - - 
Organizational support for person-centered care  The Person-Centred Care Assessment Tool (P-CAT)32 X - - - 
Organisational support for readiness for change  The Alberta Context Tool Questionnaire51 X - - - 
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Table 4.  Summary of nursing care home level data collected, outcome measures, time schedule and the type of person assessing the outcome measure 
Data collected and tool used 
P
re
- 
in
te
rve
n
tio
n
 
M
o
n
th
ly 
A
t 6
 m
o
n
th
s 
o
n
ly 
P
o
st 
in
te
rve
n
tio
n
 
      
Care home occupancy level Number of available beds to new residents S - - - 
Cost of living in the care home Fees to live in the care home S - - - 
Contributions from local government Fees paid by the local government for each resident S - - - 
Staffing levels Number and type of staff S - - - 
Number of GP practices the care home works with Number of GP practices the care home works with S - - - 
Number of GPs the care home works with Number of GPs the care home works with S - - - 
Level of need of residents in the care home Amount of support each resident needs S - - - 
Staff turnover and sickness levels Number of staff in the care home and monthly sickness record S S - - 
Ambulances and hospital use Number and length of hospital admissions (days) , A&E attendances and 
readmissions 
S S S - 
Number of hospital admissions  Respiratory infections, urinary tract infections, dehydration, congestive heart 
failure? 
S S S - 
Out of hours GP contacts GP visits or telephone contact R R R R 
Measure assessed by S: care home staff; R: researcher 
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Table 5. Data collected as part of the process evaluation.  
Outcome Measures or 
rationale for data 
collection 
Data collected 
through 
Time of data collection 
To assess carers’ 
perceptions of Namaste 
Care (intervention arm) or 
carers’ perceptions of the 
effectiveness of usual care 
(control arm) 
Interviews 
conducted by 
the researcher 
Approximately 16 – 24 weeks after the first resident 
is recruited at the nursing home. 
(If a resident dies during the trial then the informal 
carer will be approached at least 8 weeks after the 
resident’s death) 
Staff members’ 
perceptions of Namaste 
Care (intervention arm) or 
perceptions of the 
effectiveness of usual care 
(control arm) 
Interviews 
conducted by 
the researcher 
Approximately 24 weeks after the first resident is 
recruited at the nursing home 
To assess the fidelity, 
acceptability and 
appropriateness of 
Namaste Care 
(intervention arm) or 
assess effectiveness of 
usual care (Control arm) 
Observations 
conducted by 
the researcher 
Approximately 2 weeks, 4 weeks and 24 weeks after 
the start of the intervention for nursing homes in the 
intervention arm 
 
Approximately 2 weeks and 4 weeks 
after the first resident is recruited for nursing homes 
in the control arm 
 
To assess the fidelity, 
acceptability and 
appropriateness of the 
Namaste Care 
(intervention arm) 
Data log 
completed by 
the staff 
delivering the 
Namaste Care 
session 
Throughout the intervention 
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Figure 1. Flow diagram outlining the process of the study 
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Figure 1. Flow diagram outlining the process of the study  
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Usual care given over 6 month data 
collection period 
Namaste Care given over 6 month data 
collection period 
2 nursing homes allocated to the control 
arm (usual end of life care) 
6 nursing homes randomised to 
intervention arm (Namaste Care)  
Baseline data collection in nursing homes 
(data for each nursing home) 
Baseline data collection in nursing homes 
(data for each nursing home) 
Nursing home staff trained to assess 
outcome measures 
Nursing home staff trained in Namaste 
Care & how to assess outcome measures 
Participants (residents and informal carers) screened, consented and recruited in to the 
study – 4 residents recruited initially then 4 additional residents recruited in each nursing 
home over 6 month period 
 
8 nursing homes to be recruited as cluster sites  
 
Ongoing data collection 24 weeks after the first Namaste Care session 
 
Nursing homes screened in England  
Baseline data collection for participants  
Analysis of all data with presentation at the protocol development meeting 
Participants (nursing home staff) screened, consented and recruited in to the study 
 
Launch meeting between resident, informal carer and nursing home staff held in each 
nursing home 
